Reply to prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation : analysis of trends over time
- PMID: 23097014
- DOI: 10.1002/cncr.27875
Reply to prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation : analysis of trends over time
Comment on
-
Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time.Cancer. 2012 Dec 1;118(23):5768-76. doi: 10.1002/cncr.27503. Epub 2012 Jul 30. Cancer. 2012. PMID: 22847578
-
Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation : analysis of trends over time.Cancer. 2013 Mar 1;119(5):1113. doi: 10.1002/cncr.27876. Epub 2012 Oct 23. Cancer. 2013. PMID: 23097055 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
